| |
|
|
|
| Unsafe Drugs
:: Accutane
|
ACCUTANE - The FDA recorded reports of IBD (Inflammatory Bowel Disease) following Accutane use in 1997 and 2002. In May 2007, a man was awarded $2.62 million after developing Crohn’s Disease following four months of Accutane treatment. In addition to IBM and Crohn's Disease, Accutane use has been linked to Liver and Kidney Damage, Ulcerative Collitis, and Rectal Bleeding.
Also, Accutane is known to cause depression and has been blamed for many teenage suicides. Back in 2000, the suicide of Congressman Bart Stupak's 17-year old son was widely reported as being a result of the acne drug. His son was one of 66 Accutane users that committed suicide that year.
Accutane is also known to cause birth defects in pregnant women who take the drug during their pregnancy or even within a month of becoming pregnant. Accutane can lead to serious mental retardation and heart problems in the newborn baby.
If you or a loved one was prescribed Accutane or Isotretinion (the generic) and developed IBD, Crohn’s Disease, Ulcerative Collitis, rectal bleeding, birth defects, suicidal thoughts, or any other serious problem, you should have a lawyer review your case.
Unsafe drug cases are complex and costly to litigate. Experienced representation is essential, and that is exactly what we help provide. If you believe you or a loved one suffered a serious complication as a result of taking Accutane, please fill out the form below for a free evaluation.
Keywords: Accutane Lawsuit | Accutane Attorney | Accutane Lawyer | Accutane Attorneys Lawyers
|
| Free Case Evaluation |
Use the form below to submit your case and receive a free evaluation. By submitting this form, you certify that you agree to our Terms and Conditions and want us to contact you regarding your inquiry. Required fields are marked in BOLD.
|
| Accutane In the News |
Roche's Accutane Withdrawal Not Due to Safety, FDA Says - FDA news (subscription)
Roche's Accutane Withdrawal Not Due to Safety, FDA SaysFDA news (subscription)The FDA has determined that Roche's June 2009 decision to cease production of its acne treatment Accutane was not due to safety or efficacy...
More Information »
A Reckoning for REMS: FDA's Risk Program in the Spotlight - Wall Street Journal (blog)
A Reckoning for REMS: FDA's Risk Program in the SpotlightWall Street Journal (blog)The prime example: Accutane, the birth-defect-causing acne drug whose risk-management plan requires patients to register and female...
More Information »
FDA Rejects Narcotic Painkiller Program (REMS), Says Too Weak to Stop Abuse - DrugWatch.com
FDA Rejects Narcotic Painkiller Program (REMS), Says Too Weak to Stop AbuseDrugWatch.comThe FDA approved iPLEDGE in 2005. Since Accutane was first released to the public in 1982, the drug has undergone stringent label and...
More Information »
FDA Panel Votes to Restrict Avandia - New York Times
FDA Panel Votes to Restrict AvandiaNew York TimesAmong the examples of drugs the FDA has restricted are Accutane, an acne drug that can cause birth defects, and Lotronex, a drug for irritable bowel disease ...
More Information »
|
|
| |